Inadequate management of opioid-induced constipation in European cancer pain patients: results of a real-world, multicentre, observational study ("E-StOIC")
- PMID: 39367106
- DOI: 10.1007/s00520-024-08898-1
Inadequate management of opioid-induced constipation in European cancer pain patients: results of a real-world, multicentre, observational study ("E-StOIC")
Abstract
Purpose: The objectives of the study were to determine the prevalence of (uncontrolled) OIC, relevant medications / interventions employed by healthcare professionals, and the additional strategies utilised by patients, amongst European patients with cancer pain.
Methods: This study was a prospective observational study conducted at 24 research sites in ten European countries. Cancer patients receiving opioid analgesics for at least a week were recruited, and asked to complete a questionnaire including background information, single question (Are you constipated?), Rome IV diagnostic criteria for OIC, Bowel Function Index (BFI), and Patient Assessment of Constipation Quality of Life questionnaire (PAC-QOL). Participants were characterised as having / not having OIC on the basis of the Rome IV diagnostic criteria.
Results: 1200 participants completed the study. 59.5% met the Rome IV diagnostic criteria for OIC: only 61.5% that met these criteria self-reported constipation. 72% participants were prescribed a regular conventional laxative / peripherally acting mu-opioid receptor antagonist (PAMORA). However, only 66% took their prescribed laxatives every day. Many participants had utilised other strategies / interventions to manage their OIC. Furthermore, 27% had needed to use suppositories, 26.5% had needed to use an enema, and 8% had had a manual evacuation. The use of PAMORAs, and other novel effective medications, was relatively uncommon.
Conclusion: The results of this study suggest that management in Europe is often inadequate, and this undoubtedly relates to a combination of inadequate assessment, inappropriate treatment, and inadequate reassessment.
Keywords: Analgesics; Cancer pain; Neoplasms; Opioid; Opioid-induced constipation.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Constipation LPJ, diarrhoea, (2021). In: Cherny NI, Fallon MT, Kaasa S, Portenoy RK, Currow DC (eds) Oxford Textboook of Palliative Medicine, 6th edn. Oxford University Press, Oxford, pp 545–555
-
- Lindberg G, Hamid SS, Malfertheiner P, Thomsen O, Fernandez LB, Garisch J, Thomson A, Goh K, Tandon R, Fedail S, Wong B, Khan A, Krabshuis J, Le Mair A (2011) World Gastroenterology Organisation global guideline: Constipation: a global perspective. J Clin Gastroenterol 45:483–487. https://doi.org/10.1097/MCG.0b013e31820fb914 - DOI - PubMed
-
- Walter S, Hallbook O, Gotthard R, Bergmark M, Sjodahl R (2002) A population-based study on bowel habits in a Swedish community: prevalence of faecal incontinence and constipation. Scand J Gastroenterol 37:911–916. https://doi.org/10.1080/003655202760230865 - DOI - PubMed
-
- Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A (2020) MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer 28:23–33. https://doi.org/10.1007/s00520-019-05016-4 - DOI - PubMed
-
- Camilleri M, Drossman DA, Becker G, Webster LR, Davies AN, Mawe GM (2014) Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil 26:1386–1395. https://doi.org/10.1111/nmo.12417 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
